http://health.law360.com/ The Newswire for Legal Professionals Copyright 2009 Portfolio Media, Inc. en-US http://health.law360.com/images/headings/logo.gif http://health.law360.com/ http://health.law360.com/articles/132791 The Carle Foundation Hospital in Urbana, Ill., has been hit with a whistleblower action from a former employee alleging she was fired in retaliation for her repeated warnings that the Carle Hospital and the Carle Clinic had violated federal regulations intended to protect cancer patients enrolled as subjects in clinical trials. http://health.law360.com/articles/132791 http://health.law360.com/articles/132947 A jury has awarded $13.4 million to I-Flow Corp. in a suit against Apex Medical Technologies Inc. and one of its principals who I-Flow accused of patent infringement, unfair competition and stealing trade secrets related to a medical infusion pump. http://health.law360.com/articles/132947 http://health.law360.com/articles/132917 The Federal Trade Commission has launched a probe of CVS Caremark Corp., raising questions about the focus of the investigation given recent complaints from lawmakers, unions and community drugstores that the 2007 merger of the drugstore giant with a pharmacy benefits manager has curbed competition. http://health.law360.com/articles/132917 http://health.law360.com/articles/132933 Plaintiffs have dropped their putative class action accusing Pfizer Inc. of fraudulently marketing Lipitor by covering up certain side effects and misrepresenting the cholesterol drug's efficacy in some patient groups. http://health.law360.com/articles/132933 http://health.law360.com/articles/132778 Boston Scientific Corp. subsidiary Guidant Corp. will plead guilty to two misdemeanor charges and pay $296 million to end a U.S. Department of Justice probe into cardiac defibrillator product advisories it issued. http://health.law360.com/articles/132778 http://health.law360.com/articles/132915 The U.S. Department of Justice is investigating the way Abbott Laboratories has sold and marketed the anti-seizure drug Depakote, the company said Friday. http://health.law360.com/articles/132915 http://health.law360.com/articles/132801 A group of paying customers has banded together in a newly amended complaint to accuse Boehringer Ingelheim International GmbH of prosecuting a patent it knew to be invalid in order to stymie generic-drug makers in their efforts to get cheaper versions of the Parkinson's drug Mirapex to market. http://health.law360.com/articles/132801 http://health.law360.com/articles/132781 The U.S. House of Representatives has signed off on a bill that aims to address a critical shortage of medical isotopes in the U.S. by increasing federal authority and funding to jump-start domestic production while phasing out exports of highly enriched uranium to foreign isotope suppliers. http://health.law360.com/articles/132781 http://health.law360.com/articles/132727 Infosint SA has asked a judge to increase a $15 million reasonable royalty award that a jury issued for Lundbeck A/S and Forest Laboratories Inc.'s alleged infringement of a patent for making the antidepressant citalopram, arguing that it should receive additional damages and interest totaling almost $43 million. http://health.law360.com/articles/132727 http://health.law360.com/articles/132584 A federal judge has upheld a jury verdict awarding Johnson & Johnson subsidiary Centocor Ortho Biotech Inc. and New York University a record $1.67 billion for their claims that Abbott Laboratories' flagship arthritis drug Humira infringed their patent. http://health.law360.com/articles/132584 http://health.law360.com/articles/132544 The U.S. Department of Justice has named Leonard Grunstein, head of two real estate practice groups at Troutman Sanders LLP, as a defendant in a civil complaint in the still-unfolding case involving nursing home drug supply giant Omnicare Inc., which agreed Tuesday to pay $98 million to settle claims that it was part of a broad kickback scheme. http://health.law360.com/articles/132544 http://health.law360.com/articles/132537 Procter & Gamble Co. has been hit with a putative class action suit that could include more than 1 million consumers who purchased Vicks vitamin C-containing cold and flu drugs, following an Oct. 29 warning from the U.S. Food and Drug Administration that the company has been illegally marketing the products. http://health.law360.com/articles/132537 http://health.law360.com/articles/131602 The health care bill proposed last month in the U.S. House of Representatives would give the Federal Trade Commission new authority to study competition in the health insurance industry — but antitrust attorneys say that won't necessarily lead to new regulations or tougher enforcement. http://health.law360.com/articles/131602 http://health.law360.com/articles/132593 Investment firm TPG Capital LP and Canada-based pension manager CPP Investment Board will acquire IMS Health Inc., a provider of market intelligence to the health care and pharmaceutical industries, in a leveraged buyout deal valued at $5.2 billion. http://health.law360.com/articles/132593 http://health.law360.com/articles/132620 A federal judge has ordered the California Department of Health Care Services to cough up documents after siding with McKesson Corp. in a discovery battle in a proposed class action accusing the company of conspiring to inflate the average wholesale price of hundreds of drugs. http://health.law360.com/articles/132620 http://health.law360.com/articles/132475 Hansen Medical Inc. has been hit with a putative class action alleging the company issued materially false and misleading statements to shareholders regarding its financial results and compliance with generally accepted accounting principles. http://health.law360.com/articles/132475 http://health.law360.com/articles/132588 Centurion Medical Products has issued a recall, listed as a Class 1 by federal authorities, of kits containing defective pediatric tracheal tubes by Smiths Medical that could cause ventilation problems. http://health.law360.com/articles/132588 http://health.law360.com/articles/132582 A federal judge has declined to grant sanctions in a collective action over pay policies at the University of Pittsburgh Medical Center, finding that while the plaintiffs' counsel “pushed the envelope” by sending unsupervised notices to potential opt-ins, they did not actually violate any court orders. http://health.law360.com/articles/132582 http://health.law360.com/articles/132454 Shire LLC has settled yet another patent infringement suit involving Carbatrol, this time by granting Apotex Inc. a license that will allow it to sell its own generic version of the epilepsy drug. http://health.law360.com/articles/132454 http://health.law360.com/articles/132420 The six biggest U.S. health insurers spend a much lower percentage of customer premiums on medical services than industry lobbyists estimated — amounting to billions of dollars in savings, according to a new investigation from a U.S. Senate committee. http://health.law360.com/articles/132420